Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-25-306818

Chief Medical Officer sold 6,580 shares at $14.35 ($94,418)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Bedrosian Camille L Chief Medical Officer 2025-12-01 Sale −6,580 $14.35 $94,418 175,756 D
Open-market sales · 6,580 sh · avg $14.35 · $94,418
Loading xslF345X05/ownership.xml…